OneSource Specialty Pharma Ltd

OneSource Specialty Pharma Ltd Share Price Today: Live Updates & Key Insights

Get insights on OneSource Specialty Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

OneSource Specialty Pharma Ltd Share Price Chart

ONESOURCE at 06 Nov 2026 02:38 PM Pharmaceuticals

1593.40 +11.50(+0.73%)

Lowest Today 1566.00

Highest Today 1619.10

Today's Open 1581.90

Prev. Close 1581.90

52 Week High 2248.00

52 Week Low 1057.00

OneSource Specialty Pharma Ltd Fundamentals

Traded Volume: 2,22,785

Market Cap(Cr): 18,272.18

Avg Traded Price 1603.22

1 Year return -11.17%

Upper Circuit 1,619.1

Lower Circuit 1,566

P/E TTM -11249.00

P/B Ratio 3.048

Traded Value(Cr) 3549.86

EPS TTM -0.141

Book value/Share 519.070

Dividend Yield 1Y 0.00%

OneSource Specialty Pharma Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights OneSource Specialty Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the OneSource Specialty Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +1.52%

1M +7.06%

3M +2.56%

1Y -11.17%

YTD -11.51%

OneSource Specialty Pharma Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights OneSource Specialty Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 6.55L

Day Before Yesterday 4.81L

1W Avg 5.48L

1M Avg 7.96L

3M Avg 4.60L

OneSource Specialty Pharma Ltd Technical Details

OneSource Specialty Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1553

Support 2 1525

Support 3 1479

Pivot Point : 1599

Resistance 1 1627

Resistance 2 1673

Resistance 3 1701

OneSource Specialty Pharma Ltd Corporate Actions

OneSource Specialty Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on OneSource Specialty Pharma Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by ONESOURCE

Bonus

No Bonus has been declared by ONESOURCE

Splits

No Split has been declared by ONESOURCE

Others

Rights No Rights has been declared by ONESOURCE

OneSource Specialty Pharma Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares OneSource Specialty Pharma Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate OneSource Specialty Pharma Ltd's relative performance and valuation against major competitors.

Stock Name Shilpa Medicare Ltd ₹936.40 (+1.58%) M. Cap (Cr) 183.14 1 Yr Return (%) +153.97% P/E (TTM) 55.16 PB Ratio 6.83

Stock Name Alivus Life Sciences Ltd ₹1460.80 (-2.43%) M. Cap (Cr) 179.63 1 Yr Return (%) +64.04% P/E (TTM) 26.66 PB Ratio 5.11

Stock Name Caplin Point Laboratories Ltd ₹2373.60 (-1.97%) M. Cap (Cr) 180.42 1 Yr Return (%) +18.42% P/E (TTM) 27.14 PB Ratio 4.80

Stock Name OneSource Specialty Pharma Ltd ₹1593.40 (+0.73%) M. Cap (Cr) 182.72 1 Yr Return (%) -11.17% P/E (TTM) -11265.56 PB Ratio 3.12

Stock Name Alembic Pharmaceuticals Ltd ₹969.60 (+8.52%) M. Cap (Cr) 190.59 1 Yr Return (%) +5.93% P/E (TTM) 22.59 PB Ratio 3.26

Stock Name Pfizer Ltd ₹3852.10 (-0.12%) M. Cap (Cr) 176.22 1 Yr Return (%) -23.98% P/E (TTM) 20.52 PB Ratio 4.00

Stock Name ERIS Lifesciences Ltd ₹1233.00 (+0.25%) M. Cap (Cr) 171.06 1 Yr Return (%) -22.23% P/E (TTM) 24.15 PB Ratio 4.22

OneSource Specialty Pharma Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by OneSource Specialty Pharma Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2026 55.18 Mar 2025 -47.28 Mar 2024 -107.21 Mar 2023 -162.88 Mar 2022 -415.89

PARTICULARS Investing Activities Mar 2026 -477.60 Mar 2025 -300.04 Mar 2024 510.54 Mar 2023 -67.72 Mar 2022 -691.60

PARTICULARS Financing Activities Mar 2026 361.06 Mar 2025 417.22 Mar 2024 -390.54 Mar 2023 118.32 Mar 2022 1161.96

PARTICULARS Net Cash Flow Mar 2026 -61.37 Mar 2025 69.90 Mar 2024 12.79 Mar 2023 -112.28 Mar 2022 54.47

OneSource Specialty Pharma Ltd Shareholding Pattern

This shows the ownership breakdown of OneSource Specialty Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 30.47%

Public 25.86%

Other Institutions 10.44%

FII 19.45%

Mutual Funds 13.76%

About OneSource Specialty Pharma Ltd

Onesource Specialty Pharma Limited was initially incorporated as a Private Limited Company, as `Inbiopro Solutions Private Limited' dated June 12, 2007, with the Registrar of Companies, Karnataka at Bangalore. The name was then changed to `Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies. The status of the Company converted into a Public Limited Company, and renamed as `Stelis Biopharma Limited' dated July 31, 2021 and subsequently, it changed to `Onesource Specialty Pharma Limited' on February 13, 2024.In FY 2024-25, a Scheme of Arrangement amongst Strides Pharma Science Limited, Steriscience Specialties Private Limited and the Company and their respective shareholders and creditors was implemented on November 14, 2024. Prior to the Scheme of Arrangement, Strides Pharma Science Limited, Steriscience Specialties Private Limited were involved in the businesses of biologics and DDC, soft gelatin capsule and injectables business, respectively. Pursuant to the Scheme, Strides Pharma Science Limited, Steriscience Specialties Private Limited got transferred / demerged to and vested with the Company as a going concern effective on April 1, 2024 and the Scheme was made effective from November 27, 2024 with the Registrar of Companies. In accordance with the Scheme of Arrangement, 11,44,36,021 Equity Shares of Re. 1/- each have been allotted and issued. At present, Company is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. It also offers end-to-end Contract Development and Manufacturing Operations (CDMO) services across all phases of pre-clinical and clinical development and commercial supply of biologics. Company has 5 globally compliant Manufacturing Facilities. Customer list includes some of the top pharmaceutical generic companies, innovator pharmaceutical and biopharmaceutical companies, small biotechs and dedicated R&D houses, spread across the globe.The Company became the first and only CDMO with the launch of semaglutide first in India and then Canada across the multiple customer brands in 2026.

Chairman & Non Executive Dir.

Arun Kumar

Registered office 201 Devarata Sector 17 Vashi, Navi Mumbai Sanpada, Thane, Maharashtra, 400703

FAX :91-22-2789 2924/78929 08076

Background

Incorporation Year 2007

Face Value ₹1.00

Market Lot 1

OneSource Specialty Pharma Ltd Latest News

VIEW MORE NEWS

FAQs on OneSource Specialty Pharma Ltd